TELA Bio, Inc. provided revenue guidance for the year 2024. For the year, the company expects Increased full year 2024 revenue guidance to $74.5 million to $76.5 million, representing 27% to 31% year-over-year growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.53 USD | -1.60% | -5.47% | -16.47% |
05-20 | TELA Bio, Inc. Appoints Greg Firestone as Chief Commercial Officer | CI |
05-10 | Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.47% | 136M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio, Inc. Provides Revenue Guidance for the Year 2024